Close Menu

NEW YORK (GenomeWeb) — The National Institutes of Health this week announced that it has earmarked $28 million over the next four years to fund the study and refinement of clinical measures of social impairment in autism spectrum disorder.

The effort, which is being led by Yale School of Medicine's James McPartland, is being supported under the Biomarkers Consortium, a research partnership of industry, government, and academic groups focused on identifying and validating biomarkers for a variety of diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.